UNSPSC 51162021: Formoterol/mometasone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162021 Formoterol/mometasone is a Commodity code that, based on recent state and local solicitations, captures pharmaceutical products and pharmacy services rather than a single active pharmaceutical ingredient. State and local governments are buying pharmacy services, medication dispensing and management, naloxone and drug-deactivation systems, and formulary procurement through this code, frequently as part of broader employee health, community health, or public safety initiatives. Issuing bodies include county health departments, county government employee health clinics, and county purchasing offices. The work typically involves either direct procurement of specific medications and medical devices or contracting for comprehensive on-site pharmacy operations that stock, dispense, and manage medication inventories for enrolled populations.

Recent activity appears concentrated in the Southeast. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building, responses due July 26, 2023 (note: date discrepancy in source). Hall County, Georgia issued RFQ/P #47-010 in May 2026 for on-site pharmacy services at the Hall County Government Family Health Center Clinic to serve approximately 3,005 eligible individuals enrolled in the county's group health insurance plans, with responses due June 4, 2026. The Hall County solicitation emphasizes cost control and formulary management across 25 specified medications, with an 80/20 evaluation split favoring technical qualifications. Neither solicitation specifies set-aside designations.